SPRB - Spruce Biosciences  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SPRB is currently covered by 3 analysts with an average price target of $170. This is a potential upside of $3170.28 (239.52%) from yesterday's end of day stock price of $50.07.

Spruce Biosciences 's activity chart (see below) currently has 1 price targets and 10 ratings on display. The stock rating distribution of SPRB is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.48% with an average time for these price targets to be met of 17.27 days.

Highest price target for SPRB is $200, Lowest price target is $150, average price target is $170.

Most recent stock forecast was given by from JMP on 14-May-2026. First documented stock forecast 02-Nov-2020.

Currently out of the existing stock ratings of SPRB, 2 are a HOLD (25%), 6 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Nov-2025

$150

$94.89 (172.18%)

$170

1 months 28 days ago
(14-May-2026)

0/3 (0%)

$91 (154.24%)

Buy Since 22-Dec-2025

$200

$144.89 (262.91%)

$200

4 months 2 days ago
(10-Mar-2026)

0/3 (0%)

$137.21 (218.52%)

Hold Since 21-Oct-2025

$160

$104.89 (190.33%)

$160

7 months 9 days ago
(03-Dec-2025)

0/3 (0%)

$69.84 (77.46%)

Hold Since 13-Mar-2024

$37.5

$-25.54 (-40.51%)

$112.5

1 years 2 months 26 days ago
(16-Apr-2025)

3/5 (60%)

$28.27 (306.28%)

166

Hold Since 11-Dec-2024

1 years 7 months 1 days ago
(11-Dec-2024)

0/3 (0%)

$174.59 (346.34%)

Show more analysts

Please expand the browser size to see the chart

What is SPRB (Spruce Biosciences ) average time for price targets to be met?

On average it took 17.27 days on average for the stock forecasts to be realized with a an average price target met ratio 8.48

Which analyst has the current highest performing score on SPRB (Spruce Biosciences ) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on SPRB (Spruce Biosciences )?

Gregory Renza works at TRUIST and has 20 price targets and 12 ratings on SPRB

Which analyst is the currently most bullish on SPRB (Spruce Biosciences )?

Martin Auster with highest potential upside - $33687.04

Which analyst is the currently most reserved on SPRB (Spruce Biosciences )?

Gregory Renza with lowest potential downside - -$25.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?